自体移植

OBJECTIVE: To evaluate the efficacy of intracoronary autologous bone marrow mononuclear cell transplantation for the treatment of chronic heart failure.

目的：探讨自体骨髓单个核细胞移植治疗慢性心力衰竭患者的效果。

Improved in vitro purging efficiency of residual leukemia may bringabout long-term restoration of Ph-negative hematopoiesis following the clinicalapplication of autologous BMT.

自体骨髓移植是有望治愈慢粒的方法之一，但因缺乏有效的体外骨髓净化措施而限制了其在临床上的广泛应用。

Objective:To investigate the effects of transplanting autologous smooth muscle cells on cardiac function after cardiac infarction.

目的 ：研究自体平滑肌细胞移植到心肌梗死区后对心功能恢复的作用。

PURPOSE: The study was designed to use 3-D cephalometry to evaluate costochondral graft reconstruction of the mandibular condyle in goats.

目的：探讨自体肋软骨软骨移植重建生长期山羊下颌髁突的生长与改建。

RESULTS: Symptoms of all the patients undergoing bone marrow stem cell transplantation were alleviate to a certain extent. Edema and feeling of ponderosity were moderated evidently. Cicatricle was softened. The difference of affected and unaffected sides its upper limb dropsy patients was (9.2±1.4) cm before treatment, and (3.5±0.9) cm after 3 months of treatment. The difference of affected and unaffected sides in lower limb dropsy patients was (8.2±1.3) cm before treatment, and (3.7±0.6) cm after 3 months of treatment.

结果：所有接受自体骨髓干细胞移植的患者，症状均有不同程度的改善，肢体肿胀明显消退，肢体沉重感减轻，瘢痕软化，上肢水肿患者术前健侧与患侧差值为(9.2±1.4)cm，治疗后3个月为(3.5±0.9)cm，下肢水肿患者术前健侧与患侧差值为(8.2±1.3)cm，治疗后3个月为(3.7±0.6)cm。

Objective To observe osteogenesis of percutaneous autogenous bone marrow into cicatrix of bone defect.

目的 观察经皮自体骨髓移植在骨缺损瘢痕组织内的成骨作用。

Pathological change: 24 hours after operation, the brain tissue of two groups got classical pathological change of cerebral ischemia infarction. There were some mono-nucleus cells infiltrating in transplantation group while none in control group.

病理学改变：术后24 h，两组大鼠均出现典型的脑缺血梗死病理变化，自体骨髓干细胞移植组大鼠的梗死区可见少量单个核细胞，而对照组则无。

The invention provides compositions and methods, for reducing one or more symptoms of an autoimmune disease, inflammatory disease and/or transplant rejection, by the administration to a subject in need thereof a pharmaceutically effective amount purified compound of any one of Formulae A-E.

本发明是相关于药物组成物及相关方法，确切地说，是相关于通过对病体的不同需要按配方A-E中的一种对病体给药以一定量纯化的组成物，来减弱一种或多种炎性疾病，自体免疫性疾病，和移植排斥引发的一种或多种症状。

OBJECT: To investigate the ability of repairing bone defect with the compound of recombinant human IGF-I,coralline hydroxyapatite,and autogeneous red bone marrow,and the feasibility with the compounds as bone substitute materials.

目的：探讨以重组合人胰岛素样生长因子-1／珊瑚羟基磷灰石／自体红骨髓三者复合构建初步的组织工程学人工骨修复骨缺损的能力及其作为人工骨移植替代材料的可行性，并初步观察外源性IGF-Ⅰ对骨生长修复的干预效应。

Methods Six patients with total earlobe defects were treated with method of skin expansion combined with costal cartilage transplantation.

对6例耳垂完全缺损的患者使用耳后扩张皮瓣联合自体肋软骨支架移植进行修复。

This one mode pays close attention to network credence foundation of the businessman very much.

这一模式非常关注商人的网络信用基础。

Cell morphology of bacterial ghost of Pasteurella multocida was observed by scanning electron microscopy and inactivation ratio was estimated by CFU analysi.

扫描电镜观察多杀性巴氏杆菌细菌幽灵和菌落形成单位评价遗传灭活率。